<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170616034567N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-09-11</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Investigation of the effects of intramuscular electrical stimulation on trigger points</public_title>
      <acronym></acronym>
      <scientific_title>A Comparative Study of Sonographic and Clinical Parameters of Trigger Point of the Upper Fiber of the Trapezius Muscle Following " Dry Needling " and " Intramuscular Electrical Stimulation " (IMES) through Needle.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-09-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50518</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random method: balanced block randomization
Allocation concealment: sealed envelope
How to do randomization: 
To randomize by balanced block randomization method, we do the following:
Intervention group code: A  
Control group code: B
1. Due to having two groups, the designated blocks are four (AABB). The group codes in these blocks can be designed in six ways.
1(AABB), 2(BBAA), 3(ABAB), 4(BABA), 5(ABBA), 6(BAAB)
۲. Depending on the size of the sample of thirty, 8 of these blocks, which are 32 codes in total, are randomly placed next to each other.
3. Then, each of these codes, which represents the treatment group of each patient, is placed in a sealed envelope, and these envelopes are placed next to each other.
These steps will be performed by another person and the lead researcher does not know each person's group until the moment of intervention, Blinding description: In this study, the data analyzer is blinded because they do not known each patient belongs to which intervention group. 
To do this, the names of the groups are coded (intervention group: A and control group: B) and data analyzer will not know the code of each group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Upper trapezius muscle trigger point.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: intramuscular electrical stimulation, The intervention in this group was intramuscular electrical stimulation in which the patient was placed lying on his stomach. The muscle is then touched and the needle is inserted into the trigger point and the therapist's fingers. In the next step, the cathode electrode is connected to the needle and the other pole is placed on the spinous process of the seventh vertebra of the neck by a circular electrode. This will apply the current to the trigger point for 10 minutes. At the end of the mentioned period, first the current intensity is zero and then the device is removed from the patient's body and the needle is removed. Intervention 2: Control group: Dry Needling Group, In this group of patients, needling will be performed for the patient as in the previous group. In this way, after the needle enters the trigger point, the needle will move in and out. This process will continue until the insertion and removal of the twitch needle is no longer seen at the trigger point 10 times, then the needle will leave the individual muscle.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is A decision will be made after the implementation of the study.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Monavar Hadizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of rehabilitation, Shahid Beheshti University of Medical Sciences, Damavand Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7754 8496</telephone>
        <email>Hadizadeh.mahsa1992@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abbas Rahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of rehabilitation, Shahid Beheshti University of Medical Sciences, Damavand Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7754 8496</telephone>
        <email>arahimiuk@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Active trigger points in the upper trapezius muscle
Pain associated with the upper trapezius muscle trigger point above 3 based on the VAS scale which is considered as moderate pain.
Age: 18-35 years.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Perform injections or other treatments for trigger points in the period of one month before the research.
Previous history of muscle diseases such as fibromyalgia and myopathy.
Malignancy or patients prone to infection.
Central and peripheral neurological disorders.
Skin damage in the trigger point area.
Taking sedatives before and during treatment.
Radicular pain and history of neck and shoulder surgery.
Previous history of bad response to acupuncture or dry needling.
Pregnancy.
Taking anticoagulants.
Significant fear of dry needling.
Vascular disease.
Diabetes.
History of migraine.
History of accident or trauma in the relevant areas.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: intramuscular electrical stimulation, The intervention in this group was intramuscular electrical stimulation in which the patient was placed lying on his stomach. The muscle is then touched and the needle is inserted into the trigger point and the therapist's fingers. In the next step, the cathode electrode is connected to the needle and the other pole is placed on the spinous process of the seventh vertebra of the neck by a circular electrode. This will apply the current to the trigger point for 10 minutes. At the end of the mentioned period, first the current intensity is zero and then the device is removed from the patient's body and the needle is removed.</i_keyword>
      <i_keyword>Control group: Dry Needling Group, In this group of patients, needling will be performed for the patient as in the previous group. In this way, after the needle enters the trigger point, the needle will move in and out. This process will continue until the insertion and removal of the twitch needle is no longer seen at the trigger point 10 times, then the needle will leave the individual muscle.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before, after and one month after treatment. Method of measurement: by Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Pain pressure threshold. Timepoint: Before, after and one month after treatment. Method of measurement: by algometer.</prim_outcome>
      <prim_outcome>Neck range of motion. Timepoint: Before, after and one month after treatment. Method of measurement: lateral flexion and rotation by goniometer.</prim_outcome>
      <prim_outcome>Disability. Timepoint: Before, after and one month after treatment. Method of measurement: by Neck Disability Index.</prim_outcome>
      <prim_outcome>Ultrasonic parameters. Timepoint: Before, after and one month after treatment. Method of measurement: by sonography device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-09</approval_date>
        <contact_name>Ethics Committee in Biomedical Research, Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>No. 2, Shahid Beheshti University of Medical Sciences, Evin Ave, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
